News

MasterControl and i4DM have been selected as the software provider and implementation team of a quality management system (QMS) for the Food and Drug Administration (FDA). The FDA’s

Banner Pharmacaps has signed an agreement with Midway Importing for the exclusive marketing and distribution of its Gelcaps Primero la Familia product line in the US. Banner’s Gelcaps

Regulus Therapeutics (Regulus) has reported that the US Patent and Trademark Office (USPTO) has allowed a patent application within the ‘Esau’ patent family (US Application Serial No 10/909,125).

Novarts’ biological medicine Ilaris (canakinumab) has been approved in the EU to treat adults and children as young as four years old, with cryopyrin-associated periodic syndrome (CAPS). Reportedly,

The US District Court, in In re NutriSystem securities litigation, has rejected allegations that top executives of the company had made false and misleading statements about the company’s

Nektar Therapeutics (Nektar) has completed patient enrollment ahead of schedule in its phase 2 clinical study of NKTR-102 in platinum-resistant ovarian cancer. NKTR-102 is company’s investigational proprietary compound

Biomerica’s new facility is the result of a two-year search of possible buildings in the Orange County area. The manufacturing layouts have taken job and process flow into

EKR Therapeutics has received notice of patent allowance from the US Patent and Trademark Office (USPTO) for its Ready-to-Use (RTU) Cardene I.V. (nicardipine hydrochloride) Premixed Injection. Once issued,

Novavax has reported that CPL Biologicals, the new joint venture between Cadila in India, has begun construction of a manufacturing facility that will be used to produce pandemic